Christophe Douat
Director Ejecutivo en MEDINCELL S.A. .
Fortuna: 10 M $ al 30/04/2024
Cargos activos de Christophe Douat
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MEDINCELL S.A. | Director Ejecutivo | 09/01/2003 | - |
| Fundador | 09/01/2003 | - | |
| Great North SARL | Presidente | - | - |
CM Biomaterials BV
 CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Director/Miembro de la Junta | - | - |
Historial de carrera de Christophe Douat
Antiguos cargos conocidos de Christophe Douat.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NANOBIOTIX | Director/Miembro de la Junta | 28/06/2011 | 01/01/2017 |
| Independent Dir/Board Member | 28/06/2011 | 01/01/2017 | |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Inversor de Capital Privado | 01/01/2001 | 01/05/2010 |
| Matignon Technologies | Corporate Officer/Principal | 01/04/2001 | 01/04/2009 |
| NANOBIOTIX | Director/Miembro de la Junta | 01/01/2006 | 01/01/2009 |
| Sabourin Lake Lodge | Corporate Officer/Principal | 01/01/1992 | 01/01/1997 |
Matignon Technologies II FCPR
 Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Fundador | - | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formación de Christophe Douat.
| École Nationale Supérieure des Mines de Paris | Undergraduate Degree |
| University of Minnesota | Graduate Degree |
| University of Calgary | Masters Business Admin |
Estadísticas
Internacional
| Francia | 10 |
| Canadá | 3 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 5 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NANOBIOTIX | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
| Great North SARL | |
Groupement International d'Informatique de Santé SA
 Groupement International d'Informatique de Santé SA Publishing: Books/MagazinesConsumer Services Groupement International d'Informatique de Santé SA engages in the management of an online health and nutrition portal. Its services include daily effectiveness index, weekly synthesis, dietitian consultation, LeDiet community, practical tools, and chef and LeDiet recipes. The company was founded on October 9, 1986 and is headquartered in Paris, France. | Consumer Services |
CM Biomaterials BV
CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Producer Manufacturing |
| Sabourin Lake Lodge | |
| Matignon Technologies | |
Matignon Technologies II FCPR
Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Finance |
- Bolsa de valores
- Insiders
- Christophe Douat
- Experiencia
